{"nct_id":"NCT04540705","title":"A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread","status":"COMPLETED","status_verified_date":"2024-02","start_date":"2020-09-11","start_date_type":"ACTUAL","primary_completion_date":"2024-01-18","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-18","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}